NASDAQ · Medical - Diagnostics & Research

Precipio, Inc. (PRPO) Stock

$20.01 -2.91% NASDAQ: PRPO Healthcare

Valuation

MetricValue
Price$20.01
Market Cap$35.82M
P/E Ratio-36.25
P/B Ratio2.85
P/S Ratio1.53
EPS (TTM)$-0.23
52-Week High$33.63
52-Week Low$16.40
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-8.49%
ROA-5.70%
ROCE-8.77%
Gross Margin43.27%
Operating Margin-6.79%
Net Margin-4.42%
Debt/Equity0.23
Current Ratio1.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$9.0M$9.0M$15.0M$16.0M$24.0M
Operating Profit$-10.0M$-13.0M$-8.0M$-4.0M$-1.0M
Net Profit$-9.0M$-12.0M$-6.0M$-4.0M$0
EPS$-8.10$-10.73$-4.51$-2.93$-0.23
Op Margin-108.6%-136.0%-50.1%-26.4%-5.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$30.0M$22.0M$18.0M$17.0M$21.0M
Total Liabilities$6.0M$5.0M$4.0M$5.0M$7.0M
Cash$12.0M$3.0M$2.0M$1.0M$6.0M
Borrowings$1.0M$1.0M$1.0M$1.0M$4.0M

Latest News

PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy? Zacks · Jul 16, 2026 The Zacks Analyst Blog Highlights Caterpillar, Palo Alto Networks, Toyota Motor and Precipio Zacks · Jun 29, 2026 Top Analyst Reports for Caterpillar, Palo Alto & Toyota Zacks · Jun 26, 2026 Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting GlobeNewswire · Jun 12, 2026 Precipio to Present at the Planet MicroCap Las Vegas GlobeNewswire · Jun 11, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-7.0M$-8.0M$-4.0M$0$1.0M
Investing Cash Flow$-1.0M$-1.0M$0$0$-1.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$9.0M$-8.0M$-2.0M$0$1.0M
Free Cash Flow$-7.0M$-8.0M$-4.0M$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.46
EV / EBITDA171.89
FCF Yield1.88%
Quick Ratio1.56
Interest Coverage64.42
Return 1Y58.12%
Return 3Y241.67%
Return 5Y-61.18%

Ownership

Insiders Held12.65%
Institutions Held17.66%
Institutions Float Held20.21%
Institutional HolderSharesReport Date
Blackrock Inc.29,0222026-03-31
Vanguard Capital Management LLC25,4832026-03-31
Topline Capital Management, LLC24,6242026-03-31
Renaissance Technologies, LLC19,3002026-03-31
Geode Capital Management, LLC18,8112026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APUSApimeds Pharmaceuticals US, Inc. $2.89 -8.54% -0.09 $4.36M 0.00%
INTSIntensity Therapeutics, Inc. $3.25 +1.88% -0.71 $8.78M 0.00%
ITRMIterum Therapeutics plc $0.03 -10.98% -0.06 $1.60M 0.00%
LDDDLongduoduo Company Limited $0.51 +0.00% -43.59 $15.31M 0.00%
MLSSMilestone Scientific, Inc. $0.31 -2.09% -7.97 $27.64M 0.00%

About Precipio, Inc.

Precipio, Inc. is led by CEO Ilan Danieli, employs 54 people, headquartered in US, publicly traded since 2017.

Precipio, Inc. (PRPO) stock trades at $20.01 with a market capitalization of $35.82M. The stock is valued at a negative price-to-earnings (P/E) ratio of -36.25, reflecting a net loss over the last twelve months, price-to-book of 2.85, price-to-sales of 1.53. Over the past 52 weeks the stock has ranged between $16.40 and $33.63, and currently trades 40.5% below its 52-week high.

On profitability, Precipio, Inc. generates a return on equity (ROE) of -8.49% (negative, reflecting a net loss), return on capital employed of -8.77%, an operating margin of -6.79%, a net profit margin of -4.42%.

Precipio, Inc. by the numbers, 2016–2025

Between 2016 and 2025 Precipio, Inc. reported revenue of $2.0M rising to $24.0M, a change of +1100.0% across 10 years. Compounded, revenue has grown 31.9% a year over five years, 38.7% over three, 50.0% over the last twelve months. Net profit rose to $0.

Operating margin went from -502.2% in 2016 to -5.0% in 2025, a gain of 497.2 percentage points. The most recent net margin is -4.42%. On a trailing twelve-month basis to Jun '26, revenue is $27.0M and net profit $0.

Borrowings fell from $8.0M to $4.0M, cash from operations was $1.0M in the latest year, positive in 1 of the last 10.

Return on equity has averaged -37.4% over five years, and was 0.0% in the most recent year.

The share price itself has compounded at -21.7% a year over five years, 40.2% over three, 105.1% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Precipio, Inc. (PRPO) — frequently asked questions

What is Precipio, Inc. (PRPO) stock price today?

Precipio, Inc. (PRPO) is currently trading at $20.01, down 2.91% today.

What is PRPO P/E ratio?

Precipio, Inc.'s P/E ratio is -36.25. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is PRPO return on equity (ROE)?

Precipio, Inc.'s return on equity (ROE) is -8.49%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Precipio, Inc.'s market cap?

Precipio, Inc. has a market capitalization of $35.82M.

Does PRPO pay a dividend?

Precipio, Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does PRPO carry?

Precipio, Inc. has a debt-to-equity ratio of 0.23. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is PRPO's profit margin?

Precipio, Inc. reports a net profit margin of -4.42% — the share of revenue left after every cost, including tax and interest.

What sector is PRPO in?

Precipio, Inc. is classified under Healthcare, in the Medical - Diagnostics & Research industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is PRPO listed on?

Precipio, Inc. trades on NASDAQ under the ticker PRPO.

What is PRPO's 52-week range?

Over the last year Precipio, Inc. has traded between $16.40 and $33.63.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens PRPO currently matches

On the figures above, Precipio, Inc. passes the filters for 1 of our ready-made screens, among them Nano Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Nano Cap Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.